OSR HEALTH, INC. Acquisitions, Net of Cash Acquired
OSR HEALTH, INC. (OSRH) reported Acquisitions, Net of Cash Acquired of -$10.62 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2026-08-14
- OSR HEALTH, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2026-06-30 was $135.71.
- OSR HEALTH, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2026-03-31 was -$10.75K.
- OSR HEALTH, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2025-12-31 was $8.18K.
- OSR HEALTH, INC. payments to acquire businesses, net of cash acquired for the quarter ending 2025-09-30 was -$13.08K.
- OSR HEALTH, INC. payments to acquire businesses, net of cash acquired for fiscal 2025 was -$1.22M.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 3 month as first filed | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $135.71 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$10.62K 10-Q · filed 2026-08-14 | -$2.44K derived: sum of 3 quarters · filed 2026-08-14 | -$15.53K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | -$10.75K 10-Q · filed 2026-05-13 | -$2.58K derived: sum of 2 quarters · filed 2026-05-13 | -$15.66K derived: sum of 3 quarters · filed 2026-05-13 | -$36.42K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $8.18K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$4.91K derived: sum of 2 quarters · filed 2026-03-31 | -$25.67K derived: sum of 3 quarters · filed 2026-08-14 | -$1.22M 10-K · filed 2026-03-31 | |
| 2025-09-30 | -$13.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$33.84K derived: sum of 2 quarters · filed 2026-08-14 | -$1.23M 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | -$20.76K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$1.22M 10-Q · filed 2026-08-14 | |||
| 2025-03-31 | -$1.20M 10-Q · filed 2026-05-13 | -$1.20M 10-Q · filed 2025-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |